Persistent organic pollutants distribution in lipoprotein fractions in relation to cardiovascular disease and cancer

Environment International

Volumn 65, Issue , 2014, Pages 93-99

  Ljunggren, Stefan A ^a   Helmfrid, Ingela ^a   Salihovic, Samira ^b   van Bavel, Bert ^b   Wingren, Gun ^a   Lindahl, Mats ^a   Karlsson, Helen ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

Author keywords

Cancer; Cardiovascular disease; Lipoproteins; Paraoxonase 1; Persistent organic pollutants

Indexed keywords

CARDIOLOGY; DISEASES; GAS CHROMATOGRAPHY; LIPIDS; LIPOPROTEINS; MASS SPECTROMETRY; POLYCHLORINATED BIPHENYLS;

CANCER; CARDIO-VASCULAR DISEASE; HIGH-RESOLUTION GAS CHROMATOGRAPHY/HIGH-RESOLUTION MASS SPECTROMETRIES; ORGANOCHLORINE PESTICIDES; PARAOXONASE-1; PERSISTENT ORGANIC POLLUTANT (POP); PERSISTENT ORGANIC POLLUTANTS; POLYCHLORINATED BIPHENYL (PCBS);

ORGANIC POLLUTANTS;

ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; ORGANOCHLORINE PESTICIDE; POLYCHLORINATED BIPHENYL; VERY LOW DENSITY LIPOPROTEIN;

BIOACCUMULATION; CANCER; CARDIOVASCULAR DISEASE; ENZYME ACTIVITY; LIPID; ORGANIC POLLUTANT; ORGANOCHLORINE; PCB; POLLUTION EXPOSURE; PRINCIPAL COMPONENT ANALYSIS; PROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; MALE; MALIGNANT NEOPLASTIC DISEASE; MASS SPECTROMETRY; OXIDATION; PERSISTENT ORGANIC POLLUTANT; POLLUTANT; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN ISOLATION;

CANCER; CARDIOVASCULAR DISEASE; LIPOPROTEINS; PARAOXONASE-1; PERSISTENT ORGANIC POLLUTANTS;

ADULT; AGED; AGED, 80 AND OVER; ARYLDIALKYLPHOSPHATASE; CARDIOVASCULAR DISEASES; ENVIRONMENTAL POLLUTANTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; NEOPLASMS; PRINCIPAL COMPONENT ANALYSIS; YOUNG ADULT;

EID: 84892882709     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2013.12.017     Document Type: Article

References (48)

1. Abdollahi M., Ranjbar A., Shadnia S., Nikfar S., Rezaie A. Pesticides and oxidative stress: a review. Med Sci Monit 2004, 10:RA141-RA147.
2. Arehart E., Giasson G., Walsh M.T., Patterson H. Dioxin alters the human low-density and very low-density lipoprotein structure with evidence for specific quenching of Trp-48 in apolipoprotein C-II. Biochemistry 2004, 43:8503-8509. 10.1021/bi036190i.
3. Barter P. HDL-C: role as a risk modifier. Atheroscler Suppl 2011, 12:267-270. 10.1016/S1567-5688(11)70885-6.
4. Becker M.M., Gamble W. Determination of the binding of 2,4,5,2',4',5'-hexachlorobiphenyl by low density lipoprotein and bovine serum albumin. J Toxicol Environ Health 1982, 9:225-234. 10.1080/15287398209530157.
5. Brewer H.B. Clinical review: the evolving role of HDL in the treatment of high-risk patients with cardiovascular disease. J Clin Endocrinol Metab 2011, 96:1246-1257. 10.1210/jc.2010-0163.
6. Chapman J., Ginsberg H.N., Amarenco P., Andreotti F., Boren J., Catapano A.L., et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J 2011, 32:1345-1361. 10.1093/eurheartj/ehr112.
7. Costa L.G., Cole T.B., Vitalone A., Furlong C.E. Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity. Clin Chim Acta 2005, 352:37-47. 10.1016/j.cccn.2004.09.019.
8. Diamond M.L., Melymuk L., Csiszar S.A., Robson M. Estimation of PCB stocks, emissions, and urban fate: will our policies reduce concentrations and exposure?. Environ Sci Technol 2010, 44:2777-2783. 10.1021/es9012036.
9. Donato F., Magoni M., Bergonzi R., Scarcella C., Indelicato A., Carasi S., et al. Exposure to polychlorinated biphenyls in residents near a chemical factory in Italy: the food chain as main source of contamination. Chemosphere 2006, 64:1562-1572. 10.1016/j.chemosphere.2005.11.057.
10. Elkiran E.T., Mar N., Aygen B., Gursu F., Karaoglu A., Koca S. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. BMC Cancer 2007, 7:48. 10.1186/1471-2407-7-48.
11. Engel L.S., Laden F., Andersen A., Strickland P.T., Blair A., Needham L.L., et al. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin's lymphoma: a report from three cohorts. Cancer Res 2007, 67:5545-5552. 10.1158/0008-5472.CAN-06-3906.
12. Faerch K., Hojlund K., Vind B.F., Vaag A., Dalgard C., Nielsen F., et al. Increased serum concentrations of persistent organic pollutants among prediabetic individuals: potential role of altered substrate oxidation patterns. J Clin Endocrinol Metab 2012, 97:E1705-E1713. 10.1210/jc.2012-1342.
13. Gauthier M., Girard D. Activation of human neutrophils by chlordane: induction of superoxide production and phagocytosis but not chemotaxis or apoptosis. Hum Exp Toxicol 2001, 20:229-235.
14. Golden R., Kimbrough R. Weight of evidence evaluation of potential human cancer risks from exposure to polychlorinated biphenyls: an update based on studies published since 2003. Crit Rev Toxicol 2009, 39:299-331. 10.1080/10408440802291521.
15. Gupta N., Gill K., Singh S. Paraoxonases: structure, gene polymorphism & role in coronary artery disease. Indian J Med Res 2009, 130:361-368.
16. Gupta N., Binukumar B.K., Singh S., Sunkaria A., Kandimalla R., Bhansali A., et al. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population. Gene 2011, 487:88-95. 10.1016/j.gene.2011.07.011.
17. Hamers T., Kamstra J.H., Cenijn P.H., Pencikova K., Palkova L., Simeckova P., et al. In vitro toxicity profiling of ultrapure non-dioxin-like polychlorinated biphenyl congeners and their relative toxic contribution to PCB mixtures in humans. Toxicol Sci 2011, 121:88-100. 10.1093/toxsci/kfr043.
18. Hardell L., Andersson S.O., Carlberg M., Bohr L., van Bavel B., Lindstrom G., et al. Adipose tissue concentrations of persistent organic pollutants and the risk of prostate cancer. J Occup Environ Med 2006, 48:700-707. 10.1097/01.jom.0000205989.46603.43.
19. Helmfrid I., Berglund M., Lofman O., Wingren G. Health effects and exposure to polychlorinated biphenyls (PCBs) and metals in a contaminated community. Environ Int 2012, 44:53-58. 10.1016/j.envint.2012.01.009.
20. Henry T.R., DeVito M.J. Non-dioxin-like PCBs: effects and consideration in ecological risk assessment 2003, Ecological Risk Assessment Support Center, Office of Research and Development, U.S. Environmental Protection Agency, Washington, DC.
21. Hjelmborg P.S., Andreassen T.K., Bonefeld-Jorgensen E.C. Cellular uptake of lipoproteins and persistent organic compounds-an update and new data. Environ Res 2008, 108:192-198. 10.1016/j.envres.2008.07.019.
22. Hovander L., Linderholm L., Athanasiadou M., Athanassiadis I., Bignert A., Fangstrom B., et al. Levels of PCBs and their metabolites in the serum of residents of a highly contaminated area in eastern Slovakia. Environ Sci Technol 2006, 40:3696-3703.
23. Karami-Mohajeri S., Abdollahi M. Toxic influence of organophosphate, carbamate, and organochlorine pesticides on cellular metabolism of lipids, proteins, and carbohydrates: a systematic review. Hum Exp Toxicol 2011, 30:1119-1140. 10.1177/0960327110388959.
24. Karlsson H., Leanderson P., Tagesson C., Lindahl M. Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2005, 5:1431-1445. 10.1002/pmic.200401010.
25. Kim M.J., Pelloux V., Guyot E., Tordjman J., Bui L.C., Chevallier A., et al. Inflammatory pathway genes belong to major targets of persistent organic pollutants in adipose cells. Environ Health Perspect 2012, 120:508-514. 10.1289/ehp.1104282.
26. Langer P., Kocan A., Tajtakova M., Petrik J., Chovancova J., Drobna B., et al. Fish from industrially polluted freshwater as the main source of organochlorinated pollutants and increased frequency of thyroid disorders and dysglycemia. Chemosphere 2007, 67:S379-S385. 10.1016/j.chemosphere.2006.05.132.
27. Lee D.H., Steffes M.W., Sjodin A., Jones R.S., Needham L.L., Jacobs D.R. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS One 2011, 6:e15977. 10.1371/journal.pone.0015977.
28. Li J., Li N., Ma M., Giesy J.P., Wang Z. In vitro profiling of the endocrine disrupting potency of organochlorine pesticides. Toxicol Lett 2008, 183:65-71. 10.1016/j.toxlet.2008.10.002.
29. Lind P.M., van Bavel B., Salihovic S., Lind L. Circulating levels of persistent organic pollutants (POPs) and carotid atherosclerosis in the elderly. Environ Health Perspect 2012, 120:38-43. 10.1289/ehp.1103563.
30. Mackness B., Durrington P., McElduff P., Yarnell J., Azam N., Watt M., et al. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 2003, 107:2775-2779. 10.1161/01.CIR.0000070954.00271.13.
31. Maliwal B.P., Guthrie F.E. In vitro uptake and transfer of chlorinated hydrocarbons among human lipoproteins. J Lipid Res 1982, 23:474-479.
32. Mitra P.S., Ghosh S., Zang S., Sonneborn D., Hertz-Picciotto I., Trnovec T., et al. Analysis of the toxicogenomic effects of exposure to persistent organic pollutants (POPs) in Slovakian girls: correlations between gene expression and disease risk. Environ Int 2012, 39:188-199. 10.1016/j.envint.2011.09.003.
33. National Toxicology Program NTP toxicology and carcinogenesis studies of 3,3',4,4',5 pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies). Natl Toxicol Program Tech Rep Ser 2006, (520):4-246.
34. Norén K., Weistrand C., Karpe F. Distribution of PCB congeners, DDE, hexachlorobenzene, and methylsulfonyl metabolites of PCB and DDE among various fractions of human blood plasma. Arch Environ Contam Toxicol 1999, 37:408-414.
35. Pires L.A., Hegg R., Freitas F.R., Tavares E.R., Almeida C.P., Baracat E.C., et al. Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer. Braz J Med Biol Res 2012, 45:557-564.
36. Precourt L.P., Amre D., Denis M.C., Lavoie J.C., Delvin E., Seidman E., et al. The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis 2011, 214:20-36. 10.1016/j.atherosclerosis.2010.08.076.
37. Quintana F.J. The aryl hydrocarbon receptor: a molecular pathway for the environmental control of the immune response. Immunology 2013, 138:183-189. 10.1111/imm.12046.
38. Richter R.J., Jarvik G.P., Furlong C.E. Determination of paraoxonase 1 status without the use of toxic organophosphate substrates. Circ Cardiovasc Genet 2008, 1:147-152. 10.1161/CIRCGENETICS.108.811638.
39. Rosenson R.S., Brewer H.B., Davidson W.S., Fayad Z.A., Fuster V., Goldstein J., et al. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation 2012, 125:1905-1919. 10.1161/CIRCULATIONAHA.111.066589.
40. Salihovic S., Mattioli L., Lindstrom G., Lind L., Lind P.M., van Bavel B. A rapid method for screening of the Stockholm Convention POPs in small amounts of human plasma using SPE and HRGC/HRMS. Chemosphere 2012, 86:747-753. 10.1016/j.chemosphere.2011.11.006.
41. Sergeev A.V., Carpenter D.O. Exposure to persistent organic pollutants increases hospitalization rates for myocardial infarction with comorbid hypertension. Prim Prev Insights 2010, 2:1-9. 10.4137/PPRI.S4332.
42. Shen H., Robertson L.W., Ludewig G. Regulation of paraoxonase 1 (PON1) in PCB 126 exposed male Sprague Dawley rats. Toxicol Lett 2012, 209:291-298. 10.1016/j.toxlet.2012.01.003.
43. Sirivarasai J., Kaojarern S., Yoovathaworn K., Sura T. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects. Chem Biol Interact 2007, 168:184-192. 10.1016/j.cbi.2007.04.006.
44. Vomachka M.S., Vodicnik M.J., Lech J.J. Characteristics of 2,4,5,2',4',5'-hexachlorobiphenyl distribution among lipoproteins in vitro. Toxicol Appl Pharmacol 1983, 70:350-361.
45. Vonderheide A.P., Mueller K.E., Meija J., Welsh G.L. Polybrominated diphenyl ethers: causes for concern and knowledge gaps regarding environmental distribution, fate and toxicity. Sci Total Environ 2008, 400:425-436. 10.1016/j.scitotenv.2008.05.003.
46. Wayman G.A., Yang D., Bose D.D., Lesiak A., Ledoux V., Bruun D., et al. PCB-95 promotes dendritic growth via ryanodine receptor-dependent mechanisms. Environ Health Perspect 2012, 120:997-1002. 10.1289/ehp.1104832.
47. Wikoff D., Fitzgerald L., Birnbaum L. Persistent organic pollutants: an overview. Dioxins and health: including other persistent organic pollutants and endocrine disruptors 2012, 1-35. John Wiley & Sons, Inc., New Jersey. 3rd ed., 10.1002/9781118184141.ch1. A. Schecter (Ed.).
48. Wohlin M., Sundstrom J., Andren B., Larsson A., Lind L. An echolucent carotid artery intima media complex is a new and independent predictor of mortality in an elderly male cohort. Atherosclerosis 2009, 205:486-491. 10.1016/j.atherosclerosis.2009.01.032.